Inositol 1,3,4-trisphosphate 5/6-kinase inhibits tumor necrosis factor-induced apoptosis

Young Sun1, Yasuhiro Mochizuki, Philip W Majerus

  • 1Department of Internal Medicine, Division of Hematology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Insights

Inositol 1,3,4-trisphosphate 5/6-kinase (5/6-kinase) inhibits tumor necrosis factor-alpha (TNFα)-induced apoptosis by targeting the TNF-R1 pathway. This kinase modulates TNF-R1 signaling, impacting cell death independent of NF-κB activation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor necrosis factor receptor 1 (TNF-R1) signaling regulates critical cellular processes like apoptosis.
  • TNF-R1 triggers both cell death pathways and anti-apoptotic responses via NF-κB.
  • Inositol phosphate signaling pathways are crucial in cellular regulation.

Purpose of the Study:

  • To investigate the potential link between inositol phosphate signaling and TNF-R1-mediated apoptosis.
  • To elucidate the role of inositol 1,3,4-trisphosphate 5/6-kinase (5/6-kinase) in TNFα-induced cell death.

Main Methods:

  • Overexpression and RNA interference of 5/6-kinase in human cell lines (HeLa, HEK293).
  • Assessment of apoptosis markers, including caspase activation and poly(ADP-ribose) polymerase cleavage.
  • Analysis of NF-κB pathway components (DNA binding, IκBα degradation).
  • Testing apoptosis induction by various stimuli (TNFα, Fas, etoposide, cycloheximide) and death domain overexpression.

Main Results:

  • Overexpression of 5/6-kinase inhibited TNFα-induced apoptosis and caspase activation.
  • Reduced 5/6-kinase expression sensitized cells to TNFα-induced apoptosis.
  • The anti-apoptotic effect was specific to TNFα and TNF-R1-associated death domain, not Fas- or other death inducers.
  • 5/6-kinase did not affect NF-κB activation pathways.

Conclusions:

  • Inositol 1,3,4-trisphosphate 5/6-kinase (5/6-kinase) acts as a negative regulator of TNFα-induced apoptosis.
  • 5/6-kinase likely interferes with TNF-R1-associated death domain signaling, independent of NF-κB.
  • This study reveals a novel connection between inositol phosphate metabolism and TNF-R1 apoptotic signaling.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...